Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2008-1-8
pubmed:abstractText
To evaluate the impact of the two most common CYP2C9 variant alleles (*2 and *3) on the maintenance dose of warfarin and on the quality of anticoagulation control in Brazilians.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1432-1041
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
64
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
9-15
pubmed:dateRevised
2008-6-6
pubmed:meshHeading
pubmed-meshheading:17955230-Adolescent, pubmed-meshheading:17955230-Adult, pubmed-meshheading:17955230-Aged, pubmed-meshheading:17955230-Aged, 80 and over, pubmed-meshheading:17955230-Alleles, pubmed-meshheading:17955230-Anticoagulants, pubmed-meshheading:17955230-Aryl Hydrocarbon Hydroxylases, pubmed-meshheading:17955230-Brazil, pubmed-meshheading:17955230-Child, pubmed-meshheading:17955230-Dose-Response Relationship, Drug, pubmed-meshheading:17955230-Female, pubmed-meshheading:17955230-Gene Frequency, pubmed-meshheading:17955230-Genotype, pubmed-meshheading:17955230-Hemorrhage, pubmed-meshheading:17955230-Humans, pubmed-meshheading:17955230-International Normalized Ratio, pubmed-meshheading:17955230-Male, pubmed-meshheading:17955230-Middle Aged, pubmed-meshheading:17955230-Models, Genetic, pubmed-meshheading:17955230-Odds Ratio, pubmed-meshheading:17955230-Polymerase Chain Reaction, pubmed-meshheading:17955230-Polymorphism, Restriction Fragment Length, pubmed-meshheading:17955230-Risk, pubmed-meshheading:17955230-Warfarin
pubmed:year
2008
pubmed:articleTitle
CYP2C9 genotypes and the quality of anticoagulation control with warfarin therapy among Brazilian patients.
pubmed:affiliation
Departamento de Medicina Clínica, Hospital Universitário Antônio Pedro, Universidade Federal Fluminense, Rio de Janeiro, Brazil.
pubmed:publicationType
Journal Article, Controlled Clinical Trial, Research Support, Non-U.S. Gov't